2003 Licensing Pharmaceuticals Testimonials 
Drug & Device Law
FEBRUARY 20, 2023
Without an FDA license to produce another design, [defendant] was legally prohibited from distributing either [alternative design advocated by plaintiffs] at the time [plaintiff] received her vaccinations. 2003), aff’d , 810 N.Y.S.2d 7, 2022), which addressed the same question in the context of the admissibility of expert testimony.
Drug & Device Law
MAY 30, 2022
The law presumes that licensed doctors know what they are doing. The prescriber’s] testimony, however, does not establish that he would have altered his prescribing conduct. Given this testimony, the plaintiffs could not “show that stronger manufacturer warnings would have altered the physician’s prescribing conduct.”
Expert insights. Personalized for you.
59 
Let's personalize your content